SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001013762-23-001581
Filing Date
2023-10-04
Accepted
2023-10-04 16:07:53
Documents
1
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1023_tffpharma.htm DEF 14A 1136308
  Complete submission text file 0001013762-23-001581.txt   1137301
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39102 | Film No.: 231307966
SIC: 2834 Pharmaceutical Preparations